actON QbD Workshop | Episode 5: Who to Tell About the Risks?
actON QbD Workshop | Episode 5: Who to Tell About the Risks?
Identifying risks in clinical trials is only part of the process. Knowing who needs to be informed and how to communicate these risks and mitigation plans is critical to successful risk management. But what about risks that arise unexpectedly during a trial? How do you handle and share information about these new threats?
Join our experts Johann Proeve, Keith Dorricott, and Julien Nunes Goncalves for this actON QbD Workshop, where they explore effective communication strategies for clinical trial risks. Using Cyntegrity’sMyRBQM® Portal, we’ll demonstrate how technology supports clear, timely communication and keeps all stakeholders on the same page.
What You Will Learn:
-
Who should be informed about identified risks to ensure proper oversight and decision-making.
-
Best communication practices to share risks and mitigation plans effectively with clinical teams and partners.
-
How to manage and communicate emerging, unexpected risks as they arise during a study.
-
The benefits of using technology like MyRBQM® Portal to streamline communication, documentation, and tracking.
Who Should Attend:
-
Clinical Project Managers
-
Risk and Quality Managers
-
Clinical Operations Teams
-
Data and Safety Managers
-
Regulatory and Compliance Professionals
Why Attend?
Effective risk communication strengthens clinical trial oversight, improves collaboration, and supports patient safety. This workshop provides practical guidance and tools to enhance your team’s ability to communicate risks and adapt to new challenges.
Don’t Miss This Workshop!
Join us and discover how to improve risk communication in your clinical trials, ensuring everyone stays informed and ready to act when it matters most.
